Science Explorer Interactive view Map
Topic · Physiology

Histiocytic Disorders and Treatments

Histiocytic Disorders and Treatments is a research topic within Physiology. Science Explorer counts 12k research works in it since 1950. 8.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the classification, diagnosis, and treatment of histiocytic disorders, including Langerhans Cell Histiocytosis and Erdheim-Chester Disease. It explores the role of BRAF mutations, immunohistochemical approaches to classification, and consensus guidelines for clinical management. The papers also delve into the pathogenesis, molecular characterization, and therapy intensification for multisystem involvement.

  • Langerhans Cell Histiocytosis
  • Erdheim-Chester Disease
  • Dendritic Cell Neoplasms
  • BRAF Mutations
  • Clinical Management
  • Immunohistochemical Approach
  • Multisystem Involvement
  • Therapy Intensification
  • Pathogenesis
  • Molecular Characterization
Research works
12k
fractional, since 1950
In the world top 10%
926
per year above
Top-10% rate
8.0%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+19%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Histiocytic Disorders and Treatments research?

By volume, the United States and China publish the most (454 and 279 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 454 works
  2. 2 China 279 works
  3. 3 India 184 works
  4. 4 Japan 101 works
  5. 5 France 78 works
  6. 6 Brazil 69 works
  7. 7 Spain 63 works
  8. 8 Italy 62 works
  9. 9 Türkiye 47 works
  10. 10 United Kingdom 46 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 32.9%China: 20.2%India: 13.3%Japan: 7.3%6 others listed: 26.4%33%largest
United States454 · 32.9%China279 · 20.2%India184 · 13.3%Japan101 · 7.3%6 others listed364 · 26.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Histiocytic Disorders and Treatments research?

By volume in 2022–2025, All India Institute of Medical Sciences publishes the most Histiocytic Disorders and Treatments research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and Peking Union Medical College Hospital.

By volume, 2022–2025

  1. 1 All India Institute of Medical SciencesIndia 14 works
  2. 2 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 13 works
  3. 3 Peking Union Medical College HospitalChina 11 works
  4. 4 Mayo Clinic in ArizonaUnited States 10 works
  5. 5 Mayo ClinicUnited States 9 works
  6. 6 Sichuan UniversityChina 9 works
  7. 7 Post Graduate Institute of Medical Education and ResearchIndia 8 works
  8. 8 University of Alabama at BirminghamUnited States 8 works
  9. 9 Memorial Sloan Kettering Cancer CenterUnited States 7 works
  10. 10 Capital Medical UniversityChina 7 works

Where is Histiocytic Disorders and Treatments research done?

The largest centres of Histiocytic Disorders and Treatments research in 2022–2025 are Beijing (China), Paris (France), New Delhi (India) and Tokyo (Japan).

Largest cities, 2022–2025

  1. 1 Beijing China 63 works
  2. 2 Paris France 35 works
  3. 3 New Delhi India 30 works
  4. 4 Tokyo Japan 23 works
  5. 5 Chengdu China 22 works
  6. 6 São Paulo Brazil 20 works
  7. 7 Shanghai China 20 works
  8. 8 New York United States 20 works
  9. 9 Istanbul Türkiye 19 works
  10. 10 Houston United States 18 works
See Histiocytic Disorders and Treatments on the map

Where is the best place to study Histiocytic Disorders and Treatments?

Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, All India Institute of Medical Sciences and Sichuan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%5%10%mean 3.575%fractional works in this node (log) →share in the world top 10% →Chinese Academy of Medical Sciences & Peking Union Medical College: 13, 3.3%All India Institute of Medical Sciences: 14, 2.4%Sichuan University: 9, 8.6%Post Graduate Institute of Medical Education and Research: 8, 0.0%Sichuan UniversityChinese Academy of M…All India Institute …Post Graduate Instit…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 59.93.3%7.3×13 +307.8%
2 All India Institute of Medical SciencesIndia 53.62.4%13.0×14 +46.8%
3 Sichuan UniversityChina 39.08.6%2.8×9 +169.7%
4 Post Graduate Institute of Medical Education and ResearchIndia 35.60.0%13.7×8 +144.9%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Histiocytic Disorders and Treatments research growing?

Output in 2018–2022 was 19% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Histiocytic Disorders and Treatments.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.